Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT02757872 · ClinicalTrials.gov registry record · Phase 3
Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives
A Phase 3 study, sponsored by Albert Einstein College of Medicine.
- Completed
- Registry status
- Phase 3
- Development phase
- 2,232
- Enrollment target
NCT02757872 is a Phase 3 study that has completed, run by Albert Einstein College of Medicine. The registered enrollment target is 2,232 participants.
The verdict
NCT02757872, a Phase 3 study, has completed, sponsored by Albert Einstein College of Medicine.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 2,232 participants
- Enrollment target
Study Summary
The VITamin D and OmegA-3 TriaL (VITAL; NCT01169259) is an ongoing randomized clinical trial in 25,875 US men and women investigating whether taking dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor (R) fish oil, 1 gram) reduces the risk of developing cancer, heart disease, and stroke in people who do not have a prior history of these illnesses. The VITAL Kidney Function in Hypertension ancillary study will evaluate the effects of vitamin D or omega-3 fatty acids on kidney function among participants with baseline hypertension.
Interventions
- DIETARY_SUPPLEMENT Vitamin D3
- DIETARY_SUPPLEMENT Vitamin D3 placebo
- DIETARY_SUPPLEMENT Fish oil placebo
- DRUG Omega-3 Fatty acids
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,232 participants |
| Start Date | 2016-04 |
| Est. Completion | 2022-03-31 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT02757872
The ClinicalTrials.gov registry entry for NCT02757872 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 2,232 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Albert Einstein College of Medicine, which has 175 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 4 interventions - of which Vitamin D3 is the first listed.
NCT02757872 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT02757872 about?
NCT02757872 is a clinical study titled "Effects of Vitamin D and Fish Oil on the Kidney in Hypertensives". The VITamin D and OmegA-3 TriaL (VITAL; NCT01169259) is an ongoing randomized clinical trial in 25,875 US men and women investigating whether taking dietary supplements of vitamin D3 (2000 IU) or omega-3 fatty acids (Omacor (R) fish oil, 1 gram) reduces the risk of developing cancer, heart disease, ...
What is the current status of trial NCT02757872?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 2,232 participants. The study started on 2016-04. Estimated completion is 2022-03-31.
What interventions are being tested in trial NCT02757872?
The interventions under investigation include: Vitamin D3 (DIETARY_SUPPLEMENT), Vitamin D3 placebo (DIETARY_SUPPLEMENT), Fish oil placebo (DIETARY_SUPPLEMENT), Omega-3 Fatty acids (DRUG).
Who is sponsoring clinical trial NCT02757872?
This trial is sponsored by Albert Einstein College of Medicine, which has 175 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.